• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Open Forum Infect Dis . Temporal Variations in Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Infections by Race and Ethnicity i

tetano

Editor, Senior Moderator
Open Forum Infect Dis


. 2022 Mar 23;9(5):ofac154.
doi: 10.1093/ofid/ofac154. eCollection 2022 May.
Temporal Variations in Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Infections by Race and Ethnicity in Arkansas


Joshua L Kennedy[SUP] 1 2 3 [/SUP], J Craig Forrest[SUP] 4 5 6 [/SUP], Sean G Young[SUP] 7 [/SUP], Benjamin Amick[SUP] 8 [/SUP], Mark Williams[SUP] 8 [/SUP], Laura James[SUP] 1 [/SUP], Jessica Snowden[SUP] 1 [/SUP], Victor M Cardenas[SUP] 8 [/SUP], Danielle Boothe[SUP] 8 [/SUP], Catherine Kirkpatrick[SUP] 3 [/SUP], Zeel Modi[SUP] 2 [/SUP], Katherine Caid[SUP] 2 [/SUP], Shana Owens[SUP] 4 [/SUP], Marianne Kouassi[SUP] 4 [/SUP], Ryan Mann[SUP] 4 [/SUP], Claire Putt[SUP] 1 [/SUP], Katherine Irish-Clardy[SUP] 9 [/SUP], Michael Macechko[SUP] 10 [/SUP], Ronald K Brimberry[SUP] 10 [/SUP], Wendy N Nembhard[SUP] 8 [/SUP], Pearl A McElfish[SUP] 2 [/SUP], Ruofei Du[SUP] 11 [/SUP], Jing Jin[SUP] 11 [/SUP], Namvar Zohoori[SUP] 8 12 [/SUP], Atul Kothari[SUP] 2 12 13 [/SUP], Hoda Hagrass[SUP] 14 [/SUP], Ericka Olgaard[SUP] 14 [/SUP], Karl W Boehme[SUP] 4 5 6 [/SUP]



Affiliations

Abstract

Background: The aim of this study was to estimate severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection rates in the small rural state of Arkansas, using SARS-CoV-2 antibody prevalence as an indicator of infection.
Methods: We collected residual serum samples from adult outpatients seen at hospitals or clinics in Arkansas for non-coronavirus disease 2019 (COVID-19)-related reasons. A total of 5804 samples were identified over 3 time periods: 15 August-5 September 2020 (time period 1), 12 September-24 October 2020 (time period 2), and 7 November-19 December 2020 (time period 3).
Results: The age-, sex-, race-, and ethnicity-standardized SARS-CoV-2 seroprevalence during each period, from 2.6% in time period 1 to 4.1% in time period 2 and 7.4% in time period 3. No statistically significant difference in seroprevalence was found based on age, sex, or residence (urban vs rural). However, we found higher seroprevalence rates in each time period for Hispanics (17.6%, 20.6%, and 23.4%, respectively) and non-Hispanic Blacks (4.8%, 5.4%, and 8.9%, respectively) relative to non-Hispanic Whites (1.1%, 2.6%, and 5.5%, respectively).
Conclusions: Our data imply that the number of Arkansas residents infected with SARS-CoV-2 rose steadily from 2.6% in August to 7.4% in December 2020. There was no statistical difference in seroprevalence between rural and urban locales. Hispanics and Blacks had higher rates of SARS-CoV-2 antibodies than Whites, indicating that SARS-CoV-2 spread disproportionately in racial and ethnic minorities during the first year of the COVID-19 pandemic.

Keywords: COVID-19; SARS-CoV-2; antibodies; health disparities; seroprevalence; temporal variation.
 
Back
Top Bottom